Transaction · 0001100682-26-000136

Parisotto Shannon M

Parisotto Shannon M, CEVP, DISC, SA, reported a transaction classified as exercise at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. involving 2039.000000 shares for an estimated $395810.68. Reported holdings after the transaction were 6846.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCEVP, DISC, SA
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing timeAug 20
Trade dateAug 19, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$291.45
Pre-filing
1mo ago -24.6%1w ago -2.4%1d ago -4.2%
Returns since
7d +1.7%30d -3.1%90d -3.1%180d -3.1%1y -3.1%

CRL price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CRL since 2026-08-20Filed 14 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001100682-26-000136
Common Stock
Transaction date
Aug 19, 2026
Filed Aug 20, 2026, 08:33 PM · 1d delay
Shares
2.03k sh
$19.4k per share
Estimated value
$39.5M
Computed from shares × price
Holdings after
6.84k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEVP, Disc & Safety Assessment

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026.

Original filing · 0001100682-26-000136
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CRL